Dynavax Technologies Corp expected to post a loss of 13 cents a share - Earnings Preview

Dynavax Technologies

29/04/2023 03:06

* Dynavax Technologies Corp  DVAX.OQ   DVAX.O  is expected
to show
a fall in quarterly revenue when it reports  results on May 2. 
    * The Emeryville California-based  company is expected to
report 
a 66.1% decrease in revenue to $38.59 million from $113.99
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Dynavax
Technologies Corp
is for a loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dynavax
Technologies Corp is $25​, above​ its last closing price
of $10.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.43        0.43       0.45      Beat    5.3
 Sep. 30 2022  0.34        0.33       0.43      Beat    31.3
 Jun. 30 2022  0.22        0.22       0.87      Beat    295.5​
 Mar. 31 2022  0.24        0.24       0.22      Missed  -8.3
 ​​Dec.        0.61        0.64       0.55      Missed  -14.1
 31 2021                                                
 Sep. 30 2021  0.03        0.05       -0.24     Missed  -625.5
                                                        ​
 Jun. 30 2021  -0.05       -0.04      0.02      Beat    155.1
 Mar. 31 2021  -0.01       -0.02      0.01      Beat    150
 This summary was machine generated April 29 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated